Status:
COMPLETED
Myocardial Involvement of Severe Acute Respiratory Syndrome-Cov-2 (Covid19) Infected Patients
Lead Sponsor:
University Hospital, Toulouse
Conditions:
Cardiomyopathies
Eligibility:
All Genders
18+ years
Brief Summary
The effects of severe acute respiratory syndrome SARS-Cov-2 (Covid-19) on the myocardium and their role in the clinical course of infected patients are still unknown. Epidemiological studies report bi...
Detailed Description
A large population of Covid 19 infected patients of different ages and severity levels will be explored by transthoracic echocardiography with measurement of myocardial functional parameters such as e...
Eligibility Criteria
Inclusion
- Major patients hospitalized for respiratory criteria for SARS-Cov-2 infection confirmed by RT-PCR
Exclusion
- Underage patients. Patients refusing to participate in research. Patients with a history of heart disease.
Key Trial Info
Start Date :
April 4 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 2 2021
Estimated Enrollment :
122 Patients enrolled
Trial Details
Trial ID
NCT04358952
Start Date
April 4 2020
End Date
April 2 2021
Last Update
June 1 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UHToulouse
Toulouse, France, 31059